George Q. Daley is at the Division of Pediatric Hematology/Oncology, Children's Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham and Women's Hospital; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; and Harvard Stem Cell Institute. george.daley@childrens.harvard.edu
Korean scientists have generated patient-specific embryonic stem cells, providing a novel tool for disease research and accelerating prospects for therapeutic applications.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
